Compare CLLS & BRBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLLS | BRBS |
|---|---|---|
| Founded | 1999 | 1893 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 394.4M | 322.8M |
| IPO Year | 2014 | 2015 |
| Metric | CLLS | BRBS |
|---|---|---|
| Price | $3.35 | $3.58 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.33 | N/A |
| AVG Volume (30 Days) | 36.3K | ★ 422.2K |
| Earning Date | 05-08-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 24.78% |
| EPS Growth | N/A | ★ 135.48 |
| EPS | N/A | ★ 0.01 |
| Revenue | N/A | ★ $111,284,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.98 | N/A |
| P/E Ratio | ★ N/A | $359.00 |
| Revenue Growth | N/A | ★ 123.99 |
| 52 Week Low | $1.62 | $3.23 |
| 52 Week High | $5.48 | $4.79 |
| Indicator | CLLS | BRBS |
|---|---|---|
| Relative Strength Index (RSI) | 55.42 | 67.21 |
| Support Level | $2.86 | $3.24 |
| Resistance Level | $3.41 | $3.71 |
| Average True Range (ATR) | 0.16 | 0.07 |
| MACD | 0.05 | 0.03 |
| Stochastic Oscillator | 86.96 | 82.93 |
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
Blue Ridge Bankshares Inc is a United States-based company engaged in offering commercial and consumer banking and financial services through its wholly-owned bank subsidiary and its non-bank financial services affiliates. The bank offers services such as checking accounts, savings accounts, money market accounts, cash management accounts, commercial and industrial loans, residential mortgages, commercial mortgages, home equity loans, consumer installment loans, investment accounts, insurance, and others. It generates the majority of its revenue from commercial banking.